Showing 7561-7570 of 20412 results for "".
mCRPC Care: Predicting Response to Radium-223 Treatment with a PET Scan
https://reachmd.com/programs/project-oncology/mcrpc-care-predicting-response-to-radium-223-treatment-with-a-pet-scan/17798/Here’s how a PET scan may be able to predict which patients with bone metastases from castration-resistant prostate cancer may respond to radium-223.An Exploration of Current and Emerging Therapies for mCRPC
https://reachmd.com/programs/project-oncology/an-exploration-of-current-and-emerging-therapies-for-mcrpc/17799/What should we know about the current and emerging therapies for patients with mCRPC? Read more.Early Breast Cancer Care: Omitting Radiation Therapy Linked to Less Fear of Recurrence
https://reachmd.com/programs/project-oncology/early-breast-cancer-care-omitting-radiation-therapy-linked-to-less-fear-of-recurrence/16359/Read more to learn about the compelling evidence of EBC from the PROSPECT (ANZ-1002) study.How to Reduce Harm for Patients in Family Planning Clinics Who Use Substances
https://reachmd.com/programs/advances-in-womens-health/how-to-reduce-harm-for-patients-in-family-planning-clinics-who-use-substances/16167/Explore strategies for reducing harm among substance-using pregnant patients with this recap of a session featured at the 2023 SFP Annual Meeting.Educating Nurse Practitioners on Perinatal Mental Health
https://reachmd.com/programs/advances-in-womens-health/educating-nurse-practitioners-on-perinatal-mental-health/16172/How can nurse practitioners be better equipped to serve pregnant and postpartum patients experiencing perinatal mental health disorders?Discussing Disparities in MS Care for Underrepresented Populations
https://reachmd.com/programs/neurofrontiers/discussing-disparities-in-ms-care-for-underrepresented-populations/15895/What challenges do patients with MS in underrepresented populations face, and how can we close these treatment gaps?An Overview of MS Biomarkers
https://reachmd.com/programs/neurofrontiers/an-overview-of-ms-biomarkers/16248/Which biomarkers help us diagnose and monitor disease progression and medication response in MS?Cardio-Oncology: Key Clinical Data from ACC.23
https://reachmd.com/programs/acc-action-center/cardio-oncology-key-clinical-data-from-acc23/15144/Get the latest clinical data in cardio-oncology from the American College of Cardiology's 72nd Scientific Session & Expo.Tips To Nurture Leads
https://reachmd.com/topics/practice-development/tips-to-nurture-leads/35211/Grow your practice by converting leads to patients.Advances in Temporal Lobe Epilepsy Research
https://reachmd.com/programs/neurofrontiers/advances-in-temporal-lobe-epilepsy-research/13956/Thanks to recent research, could we now have a better understanding of the risk of neurodegeneration among patients with temporal lobe epilepsy?